NET Alliance launches
This year, Novartis launches the NET Alliance. The NET Alliance is a unique, long-term commitment from Novartis to NET patients and physicians to improve patient outcomes by advancing the knowledge and management of neuroendocrine tumours.
Watch this space as we post up more information booklets from the NET Alliance
